<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="iso-abbrev">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="doi">10.5812/ircmj</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Iranian Red Crescent Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">2074-1804</issn><issn pub-type="epub">2074-1812</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25558382</article-id><article-id pub-id-type="pmc">4270663</article-id><article-id pub-id-type="doi">10.5812/ircmj.16239</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Comparing the Healing Effects of <italic>Arnebia euchroma</italic> Ointment With Petrolatum on the Ulcers Caused by Fractional CO<sub>2</sub> Laser: A Single-Blinded Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Aliasl</surname><given-names>Jale</given-names></name><xref ref-type="aff" rid="aff45477">1</xref></contrib><contrib contrib-type="author"><name><surname>Khoshzaban</surname><given-names>Fariba</given-names></name><xref ref-type="aff" rid="aff45477">1</xref><xref ref-type="corresp" rid="cor45478">*</xref></contrib><contrib contrib-type="author"><name><surname>Barikbin</surname><given-names>Behrooz</given-names></name><xref ref-type="aff" rid="aff45479">2</xref><xref ref-type="corresp" rid="cor45478">*</xref></contrib><contrib contrib-type="author"><name><surname>Naseri</surname><given-names>Mohsen</given-names></name><xref ref-type="aff" rid="aff45477">1</xref></contrib><contrib contrib-type="author"><name><surname>Kamalinejad</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff45481">3</xref></contrib><contrib contrib-type="author"><name><surname>Emadi</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="aff45477">1</xref></contrib><contrib contrib-type="author"><name><surname>Razzaghi</surname><given-names>Zahra</given-names></name><xref ref-type="aff" rid="aff45479">2</xref></contrib><contrib contrib-type="author"><name><surname>Talei</surname><given-names>Daryush</given-names></name><xref ref-type="aff" rid="aff45482">4</xref></contrib><contrib contrib-type="author"><name><surname>Yousefi</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="aff45483">5</xref></contrib><contrib contrib-type="author"><name><surname>Aliasl</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="aff45484">6</xref></contrib><contrib contrib-type="author"><name><surname>Barati</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="aff45479">2</xref></contrib><contrib contrib-type="author"><name><surname>Mohseni-Moghaddam</surname><given-names>Parvaneh</given-names></name><xref ref-type="aff" rid="aff45477">1</xref></contrib><contrib contrib-type="author"><name><surname>Hasheminejad</surname><given-names>Seyed Abbas</given-names></name><xref ref-type="aff" rid="aff45477">1</xref></contrib><contrib contrib-type="author"><name><surname>Esmailzad Nami</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="aff45477">1</xref></contrib></contrib-group><aff id="aff45477"><label>1</label>Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, IR Iran</aff><aff id="aff45479"><label>2</label>Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff45481"><label>3</label>Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff45482"><label>4</label>Medicinal Plant Research Center, Shahed University, Tehran, IR Iran</aff><aff id="aff45483"><label>5</label>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff45484"><label>6</label>Department of Traditional Pharmacy, Faculty of Traditional Medicine, Tehran University of Medical Sciences, Tehran, IR Iran</aff><author-notes><corresp id="cor45478"><label>*</label>Corresponding Authors: Behrooz Barikbin, Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran. Tel: +98-2122741507, Fax: +98-2122744393, E-mail: <email>bbarikbin@yahoo.com</email>; Fariba Khoshzaban, Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, IR Iran. Tel: +98-2188964792, Fax: +98-2188966310, E-mail: <email>fkhosh_99@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2014</year></pub-date><volume>16</volume><issue>10</issue><elocation-id>e16239</elocation-id><history><date date-type="received"><day>29</day><month>11</month><year>2013</year></date><date date-type="rev-recd"><day>04</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014, Iranian Red Crescent Medical Journal; Published by Kowsar. </copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p><italic>Arnebia euchroma</italic> ointment (AEO) has been used in Iranian traditional medicine for burn wound healing.</p></sec><sec><title>Objectives:</title><p>The aim of this study is to evaluate wound healing efficacy of AEO in burn wounds after fractional Co2 laser.</p></sec><sec><title>Patients and Methods:</title><p>This split-face, single-blinded, single-center clinical study was performed in Shohada-e-Tajrish Hospital, Tehran, Iran. A total of 26 subjects with facial acne scar, who were to receive fractional CO<sub>2</sub> laser resurfacing were recruited. After laser procedure, AEO was applied to one side of the face and petrolatum on the other side for wound healing. Digital photographs were taken from acne scar area before resurfacing and on each of the assessment sessions. Three researchers, who were unaware of the applied medications, assessed these digital photographs for erythema, edema, epithelial confluence, crusting/scabbing, and general wound appearance. Subject&#x02019;s irritations such as dryness and itching were evaluated on the second, fifth, and seventh days.</p></sec><sec><title>Results:</title><p>Our study indicated higher epithelial confluence and general wound appearance scores (P = 0.045 for both) and less erythema and edema on fifth day in petrolatum (P = 0.009 and P = 0.034, respectively). The results showed less crusting and erythema (P = 0.016 and P = 0.035, respectively) and higher general wound appearance scores in petrolatum on the second day (P = 0.035 and P = 0.001, respectively). Dryness was the most common subjective complaint in both groups; however, it was more severe in AEO, especially on the second day (P = 0.023).</p></sec><sec><title>Conclusions:</title><p>Despite the healing effects of AEO in burn wounds, petrolatum was more effective than AEO in post-laser wound.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Acne</kwd><kwd>Arnebia</kwd><kwd>Traditional Medicine</kwd><kwd>Laser</kwd><kwd>Wound Healing</kwd></kwd-group></article-meta></front><body><sec id="sec72037"><title>1. Background</title><p>Acne is one of the most common diseases in adolescents that can lead to atrophic scars (<xref rid="A16239R1" ref-type="bibr">1</xref>). There are many treatment modalities for acne scars (<xref rid="A16239R2" ref-type="bibr">2</xref>). Ablative fractional carbon dioxide (CO<sub>2</sub>) laser is the most frequently used (<xref rid="A16239R3" ref-type="bibr">3</xref>) and the gold standard therapeutic method for acne scar (<xref rid="A16239R4" ref-type="bibr">4</xref>). Ablative fractional resurfacing (AFR) is a combination of ablative technology and fractional photothermolysis (<xref rid="A16239R4" ref-type="bibr">4</xref>). Fractional ablative laser creates microscopic columns injury, termed microscopic thermal zones (MTZs), on the dermis that are surrounded by columns of normal tissue. These microscopic lesions are healed very quickly with limited complications (<xref rid="A16239R5" ref-type="bibr">5</xref>-<xref rid="A16239R7" ref-type="bibr">7</xref>). AFR produces skin damage and removes the epidermis and variable portions of the dermis (<xref rid="A16239R8" ref-type="bibr">8</xref>). Topical ointments, cold compresses, and diluted solutions of acetic acid promote post-laser wound healing and reduce swelling (<xref rid="A16239R6" ref-type="bibr">6</xref>, <xref rid="A16239R9" ref-type="bibr">9</xref>). Therapeutic effects of current treatments are not satisfactory and petrolatum is still the standard treatment for laser wound care (<xref rid="A16239R10" ref-type="bibr">10</xref>). Treatment should speed up re-epithelialization and reduce rest time, with minimal irritation (<xref rid="A16239R11" ref-type="bibr">11</xref>). Unfortunately, there is no standard care for post-laser resurfacing treatment of the face (<xref rid="A16239R6" ref-type="bibr">6</xref>). Since ancient times, plants have been used as rich sources of effective and safe medicines. About 80% of world populations are still dependent on traditional medicines (<xref rid="A16239R12" ref-type="bibr">12</xref>). <italic>Arnebia euchroma</italic> (Royle) Johnst from the Boraginaceae family grows in alpine region, Asia (especially in Iran), Himalaya, and North Africa (<xref rid="A16239R13" ref-type="bibr">13</xref>, <xref rid="A16239R14" ref-type="bibr">14</xref>). Its prominent components are shikonin and alkannin. They have widespread pharmacologic properties including anti-inflammatory and antimicrobial (<xref rid="A16239R15" ref-type="bibr">15</xref>). <italic>Arnebia euchroma</italic> is known as Havachoobeh in Iranian traditional medicine (ITM) (<xref rid="A16239R16" ref-type="bibr">16</xref>) and is named Abukhalsa in "Canon of Medicine" (written by Avicenna) (<xref rid="A16239R17" ref-type="bibr">17</xref>). It is traditionally used to treat infective and burn wounds (<xref rid="A16239R17" ref-type="bibr">17</xref>, <xref rid="A16239R18" ref-type="bibr">18</xref>). It has also pain relief properties (<xref rid="A16239R19" ref-type="bibr">19</xref>). There are many topical compounds of <italic>A. euchroma</italic> for burn wounds healing in ITM, one of which is &#x0201c;Marhame Havachoobeh&#x0201d; (<italic>A. euchroma</italic> ointment [AEO]) (<xref rid="A16239R16" ref-type="bibr">16</xref>).</p></sec><sec id="sec72038"><title>2. Objectives</title><p>The purpose of this study was to determine the healing effects of AEO on post-laser wound healing in patients with acne scar in comparison with petrolatum. It was the first clinical trial that evaluated effects of <italic>A. euchroma</italic> compound on wound healing in patients with post-laser resurfacing acne scar.</p></sec><sec id="sec72043"><title>3. Patients and Methods</title><sec id="sec72039"><title>3.1. Preparation of Arnebia euchroma Ointment</title><p>The dried roots of <italic>A. euchroma</italic> were purchased from local market in Tehran Bazaar, identified by Professor Gholamreza Amin, and were kept at the herbarium of faculty of pharmacy, Tehran University of Medicinal Sciences, under the voucher number PMP-216. AEO was made from <italic>A. euchroma</italic> roots (10 g), sesame (<italic>Sesamum indicum</italic>) oil (100 g), and Wax (10 g), with the weight ratio of 1:10:1 (<xref rid="A16239R16" ref-type="bibr">16</xref>). The dried roots of <italic>A. euchroma</italic> were chopped and heated in sesame oil at 40&#x02103; to 60&#x02103; for 12 hours. Then samples were filtered and mixed with melted Wax and filled in tubes. Petrolatum was filled in similar tubes. Since the red color and smell of AEO was different from those of petrolatum, the blindness of patients was not possible.</p></sec><sec id="sec72040"><title>3.2. Subjects and Intervention</title><p>This split-face, single-blind, single-center, clinical study was performed in Laser Research Center of Shahid Beheshti University of Medical Sciences, Shohada-e-Tajrish Hospital, Tehran, Iran. A total of 47 subjects with the Fitzpatrick skin phototype of II to IV, 20 to 65 years of age, and mild to severe bilateral facial atrophic acne scars, who referred for laser resurfacing, were evaluated to enroll in the study (The Fitzpatrick Scale [also Fitzpatrick skin typing test or Fitzpatrick photo typing scale] is a numerical classification schema for the color of skin. It remains a recognized tool for dermatologic research into the color of skin It measures several components: Genetic Disposition, Reaction to Sun Exposure, and Tanning Habits. The Fitzpatrick Scale: Type I (scores 0&#x02013;7) Light, pale white.(Always burns, never tans), Type II (scores 8&#x02013;16) White; fair. (Usually burns, tans with difficulty), Type III (scores 17&#x02013;24) Medium, white to olive. (Sometimes mild burn, gradually tans to olive), Type IV (scores 25&#x02013;30) Olive, moderate brown. (Rarely burns, tans with ease to a moderate brown), Type V (scores over 30) Brown, dark brown (Very rarely burns, tans very easily), Type VI Black, very dark brown to black.(Never burns, tans very easily, deeply pigmented). Subjects were excluded if they had any known allergy or sensitivity to lotions, moisturizers, creams, or healing ointments. In addition, pregnant women and subjects who received isotretinoin or topical drugs simultaneously or had active acne in faces were excluded. Written informed consent was obtained from each subject. </p><p>Before resurfacing, the patient&#x02019;s acne scar area was cleaned and a topical anesthetic mixture (lidocaine, prilocaine) was applied. Then, resurfacing was performed using a MIXEL-CO2 Fractional Laser system (Hironic Co, Ltd., Korea) with the following setting parameters: energy, 20 to 50 mJ; distance, 0.7 to 0.9 mm; and the number of passes, one to three depending on the severity of the acne scar. After fractional CO<sub>2</sub> laser resurfacing, cold compress was applied. AEO and petrolatum were used to opposite sides of the face four times a day (morning, midday, evening, and bedtime) for one week. The Ethics Committee of Shahed University approved the protocol (approval number: 148489). The study conformed to the Helsinki Declaration of 1975 and was registered in the Iranian Registry of Clinical Trials (No., IRCT201109067499N1).</p></sec><sec id="sec72041"><title>3.3. Measurement of Wound Healing</title><p>Subjects visited on the second, fifth, and seventh days of procedure to take digital photographs and to be assessed for subjective irritation parameters (burning, itching, dryness, and pain) by using four-point grading scales (<xref ref-type="table" rid="tbl18353">Table 1</xref>). Any adverse events including the presence of purulent discharge or infection were recorded. At the end of the study, three blinded expert researchers (dermatologist), who were unaware of assigned treatment to each side, observed digital photographs for assessment of wound-healing efficacy. Erythema, edema, crusting/scabbing, epithelial confluence, and general wound appearance were evaluated assessed using the five-point grading scales (<xref ref-type="table" rid="tbl18353">Table 1</xref>) to determine the efficacy of wound healing. </p><table-wrap id="tbl18353" orientation="portrait" position="float"><label>Table 1.</label><caption><title> Grading Score</title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">Scale</th></tr></thead><tbody><tr style="vertical-align: top"><td rowspan="1" colspan="1">
<bold>Erythema</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0 = None or Absent, 1 = Mild, 2 = Moderate, 3 = Marked, and 4 = Severe</td></tr><tr style="vertical-align: top"><td rowspan="1" colspan="1">
<bold>Edema</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0 = None or Absent, 1 = Mild, 2 = Moderate, 3 = Marked, and 4 = Severe</td></tr><tr style="vertical-align: top"><td rowspan="1" colspan="1">
<bold>Epithelial Confluence</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0 = None, 1 = Slight (Up to 30%), 2 = Moderate (31%-60%), 3 = Extensive (61%-90%), and 4 = Almost Complete (91%-100%)</td></tr><tr style="vertical-align: top"><td rowspan="1" colspan="1">
<bold>Crusting/Scabbing</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0 = None, 1 = Slight (Up to 29%), 2 = Moderate (30%-59%), 3 = Extensive (60%-90%), and 4 = Almost Complete (91%-100%)</td></tr><tr style="vertical-align: top"><td rowspan="1" colspan="1">
<bold>General Wound Appearance</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">0 = Poor, 1 = Fair, 2 = Good, 3 = Very Good, and 4 = Excellent</td></tr><tr style="vertical-align: top"><td rowspan="1" colspan="1">
<bold>Subjective Irritation</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr style="vertical-align: top"><td style="padding-left: 20pt;" rowspan="1" colspan="1">Burning</td><td style="text-align: center;" rowspan="1" colspan="1"> 0 = none or absent, 1 = mild, 2 = moderate, 3 = severe or extreme</td></tr><tr style="vertical-align: top"><td style="padding-left: 20pt;" rowspan="1" colspan="1">Itching</td><td style="text-align: center;" rowspan="1" colspan="1"> 0 = none or absent, 1 = mild, 2 = moderate, 3 = severe or extreme</td></tr><tr style="vertical-align: top"><td style="padding-left: 20pt;" rowspan="1" colspan="1">Pain</td><td style="text-align: center;" rowspan="1" colspan="1"> 0 = none or absent, 1 = mild, 2 = moderate, 3 = severe or extreme</td></tr><tr style="vertical-align: top"><td style="padding-left: 20pt;" rowspan="1" colspan="1">Dryness</td><td style="text-align: center;" rowspan="1" colspan="1">0 = none or absent, 1 = mild, 2 = moderate, 3 = severe or extreme</td></tr></tbody></table></table-wrap></sec><sec id="sec72042"><title>3.4. Statistical Analysis</title><p>Sample size was determined according to the following formula:</p><p><inline-formula>N = (1/1 - f) [2 (z<sub>1 - &#x003b1;</sub> + z&#x003b2;)<sup>2 </sup>(&#x003b1;<sup>2</sup>)/d<sup>2</sup>]</inline-formula></p><p>With the power of 90%, the number of required patients to complete each treatment arm was calculated at 24. SPSS 16 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Results were reported as the mean &#x000b1; standard deviation. Chi square test was used for comparison of the frequency of variables between two groups. Student t test was used to compare quantitative variables. P value &#x0003c; 0.05 was considered as statistically significant.</p></sec></sec><sec id="sec72044"><title>4. Results</title><p>From February to June 2012, 47 subjects with mild to severe bilateral atrophic facial acne scars, who were referred for laser resurfacing, were enrolled. Three subjects who had active acne (n = 2) or received isotretinoin (n = 1) were excluded. Eighteen subjects discontinued their therapy. The main reasons of dropping out of the study were lack of effect, not attending for taking digital photographs, and personal reasons. Finally, 26 patients, 17 females (65.4%) and nine males (34.6%) completed the study. The mean age was 29 years (range, 20-50). In comparison to AEO, petrolatum showed significantly less erythema and crusting (P = 0.035, P = 0.016 respectively) and higher general wound appearance scores on the second day (P = 0.001) and less erythema and edema on the fifth day of therapy (P = 0.009 and P = 0.034, respectively) (<xref ref-type="table" rid="tbl18354">Table 2</xref>). In addition, petrolatum had higher epithelial confluence and general wound appearance scores on the fifth day of therapy (P = 0.045 in both) (<xref ref-type="table" rid="tbl18354">Table 2</xref>). Subjective assessments of irritation demonstrated no significant difference in erythema, edema, itching, burning, and pain between groups at any time point (<xref ref-type="table" rid="tbl18355">Table 3</xref>). Both treatments showed good safety profile and there were no serious adverse reactions. The most common unpleasant complaints were dryness in both groups; however, it was more severe in AEO, especially at second day (P = 0.023) with no significant differences at the fifth and seventh days (<xref ref-type="table" rid="tbl18355">Table 3</xref>). No incidence of purulent discharge or infection was seen with any of the study treatments. At the end of the study, 14 subjects (53.8%) judged the petrolatum treated side that looked better and only six (23%) preferred AEO (P &#x02264; 0.02). Most patients did not like to use AEO on the other half of their faces because of its red color.</p><table-wrap id="tbl18354" orientation="portrait" position="float"><label>Table 2.</label><caption><title> Comparison of Treatments With <italic>Arnebia euchroma</italic> Ointment and Petrolatum in Clinical Grading Scores by Researchers<sup><xref ref-type="table-fn" rid="fn15381">a</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Day</th><th rowspan="1" colspan="1">Petrolatum</th><th rowspan="1" colspan="1"><italic>Arnebia euchroma</italic> Ointment</th><th rowspan="1" colspan="1">P Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Erythema</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">2.28 &#x000b1; 0.61</td><td style="text-align: center;" rowspan="1" colspan="1">2.62 &#x000b1; 0.53</td><td style="text-align: center;" rowspan="1" colspan="1">0.035<sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">1.26 &#x000b1; 0.40</td><td style="text-align: center;" rowspan="1" colspan="1">1.63 &#x000b1; 0.46</td><td style="text-align: center;" rowspan="1" colspan="1">0.009<sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">0.68 &#x000b1; 0.58</td><td style="text-align: center;" rowspan="1" colspan="1">0.70 &#x000b1; 0.47</td><td style="text-align: center;" rowspan="1" colspan="1">0.873</td></tr><tr><td rowspan="1" colspan="1">
<bold>Edema</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.13 &#x000b1; 0.27</td><td style="text-align: center;" rowspan="1" colspan="1">1.29 &#x000b1; 0.34</td><td style="text-align: center;" rowspan="1" colspan="1">0.071</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">0.58 &#x000b1; 0.25</td><td style="text-align: center;" rowspan="1" colspan="1">0.77 &#x000b1; 0.27</td><td style="text-align: center;" rowspan="1" colspan="1">0.034<sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">0.09 &#x000b1; 0.15</td><td style="text-align: center;" rowspan="1" colspan="1">0.10 &#x000b1; 0.21</td><td style="text-align: center;" rowspan="1" colspan="1">0.789</td></tr><tr><td rowspan="1" colspan="1">
<bold>Crusting/Scabbing</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.21 &#x000b1; 0.45</td><td style="text-align: center;" rowspan="1" colspan="1">1.56 &#x000b1; 0.54</td><td style="text-align: center;" rowspan="1" colspan="1">0.016<sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">0.79 &#x000b1; 0.63</td><td style="text-align: center;" rowspan="1" colspan="1">0.99 &#x000b1; 0.64</td><td style="text-align: center;" rowspan="1" colspan="1">0.362</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">0.25 &#x000b1; 0.27</td><td style="text-align: center;" rowspan="1" colspan="1">0.19 &#x000b1; 0.28</td><td style="text-align: center;" rowspan="1" colspan="1">0.473</td></tr><tr><td rowspan="1" colspan="1">
<bold>Epithelial Confluence</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.55 &#x000b1; 0.32</td><td style="text-align: center;" rowspan="1" colspan="1">1.39 &#x000b1; 0.41</td><td style="text-align: center;" rowspan="1" colspan="1">0.141</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">2.28 &#x000b1; 0.41</td><td style="text-align: center;" rowspan="1" colspan="1">1.98 &#x000b1; 0.46</td><td style="text-align: center;" rowspan="1" colspan="1">0.045<sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">2.51 &#x000b1; 0.30</td><td style="text-align: center;" rowspan="1" colspan="1">2.54 &#x000b1; 0.28</td><td style="text-align: center;" rowspan="1" colspan="1">0.734</td></tr><tr><td rowspan="1" colspan="1">
<bold>General Wound Appearance</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.44 &#x000b1; 0.26</td><td style="text-align: center;" rowspan="1" colspan="1">0.88 &#x000b1; 0.25</td><td style="text-align: center;" rowspan="1" colspan="1">0.001<sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">2.42 &#x000b1; 0.42</td><td style="text-align: center;" rowspan="1" colspan="1">2.14 &#x000b1; 0.40</td><td style="text-align: center;" rowspan="1" colspan="1">0.045<sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">3.05 &#x000b1; 0.42</td><td style="text-align: center;" rowspan="1" colspan="1">2.99 &#x000b1; 0.37</td><td style="text-align: center;" rowspan="1" colspan="1">0.616</td></tr></tbody></table><table-wrap-foot><fn id="fn15381"><p><sup>a</sup> Data are presented as mean &#x000b1; SD.</p></fn><fn id="fn15382"><p><sup>b</sup> Significant at P &#x02264; 0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl18355" orientation="portrait" position="float"><label>Table 3.</label><caption><title> Comparison of Treatments With <italic>Arnebia euchroma</italic> Ointment and Petrolatum by Subjects <sup><xref ref-type="table-fn" rid="fn15383">a</xref>,<xref ref-type="table-fn" rid="fn15384">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Day</th><th rowspan="1" colspan="1">Petrolatum</th><th rowspan="1" colspan="1"><italic>Arnebia euchroma</italic> Ointment</th><th rowspan="1" colspan="1">P Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Dryness</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.96 &#x000b1; 0.95</td><td style="text-align: center;" rowspan="1" colspan="1">2.65 &#x000b1; 1.16</td><td style="text-align: center;" rowspan="1" colspan="1">0.023 <sup><xref ref-type="table-fn" rid="fn15382">b</xref></sup></td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">1.84 &#x000b1; 1.15</td><td style="text-align: center;" rowspan="1" colspan="1">2.42 &#x000b1; 1.41</td><td style="text-align: center;" rowspan="1" colspan="1">0.114</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">1.57 &#x000b1; 1.06</td><td style="text-align: center;" rowspan="1" colspan="1">2.03 &#x000b1; 1.34</td><td style="text-align: center;" rowspan="1" colspan="1">0.175</td></tr><tr><td rowspan="1" colspan="1">
<bold>Itching</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.88 &#x000b1; 0.95</td><td style="text-align: center;" rowspan="1" colspan="1">1.84 &#x000b1; 0.88</td><td style="text-align: center;" rowspan="1" colspan="1">0.876</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">1.53 &#x000b1; 0.98</td><td style="text-align: center;" rowspan="1" colspan="1">2.00 &#x000b1; 1.13</td><td style="text-align: center;" rowspan="1" colspan="1">0.124</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">1.15 &#x000b1; 0.67</td><td style="text-align: center;" rowspan="1" colspan="1">1.23 &#x000b1; 0.65</td><td style="text-align: center;" rowspan="1" colspan="1">0.678</td></tr><tr><td rowspan="1" colspan="1">
<bold>Edema</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.34 &#x000b1; 0.79</td><td style="text-align: center;" rowspan="1" colspan="1">1.46 &#x000b1; 0.90</td><td style="text-align: center;" rowspan="1" colspan="1">0.628</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">1.11 &#x000b1; 0.65</td><td style="text-align: center;" rowspan="1" colspan="1">1.26 &#x000b1; 0.66</td><td style="text-align: center;" rowspan="1" colspan="1">0.405</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">1.07 &#x000b1; 0.62</td><td style="text-align: center;" rowspan="1" colspan="1">1.11 &#x000b1; 0.65</td><td style="text-align: center;" rowspan="1" colspan="1">0.829</td></tr><tr><td rowspan="1" colspan="1">
<bold>Erythema</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">2.07 &#x000b1; 1.12</td><td style="text-align: center;" rowspan="1" colspan="1">2.57 &#x000b1; 1.36</td><td style="text-align: center;" rowspan="1" colspan="1">0.156</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">1.76 &#x000b1; 1.21</td><td style="text-align: center;" rowspan="1" colspan="1">2.19 &#x000b1; 1.32</td><td style="text-align: center;" rowspan="1" colspan="1">0.235</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">1.76 &#x000b1; 1.06</td><td style="text-align: center;" rowspan="1" colspan="1">2.07 &#x000b1; 1.26</td><td style="text-align: center;" rowspan="1" colspan="1">0.348</td></tr><tr><td rowspan="1" colspan="1">
<bold>Pain</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.38 &#x000b1; 0.80</td><td style="text-align: center;" rowspan="1" colspan="1">1.46 &#x000b1; 0.81</td><td style="text-align: center;" rowspan="1" colspan="1">0.733</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">0.92 &#x000b1; 0.27</td><td style="text-align: center;" rowspan="1" colspan="1">1.07 &#x000b1; 0.27</td><td style="text-align: center;" rowspan="1" colspan="1">0.742</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">1.03 &#x000b1; 0.52</td><td style="text-align: center;" rowspan="1" colspan="1">0.92 &#x000b1; 0.27</td><td style="text-align: center;" rowspan="1" colspan="1">1.000</td></tr><tr><td rowspan="1" colspan="1">
<bold>Burning</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.96 &#x000b1; 1.03</td><td style="text-align: center;" rowspan="1" colspan="1">2.19 &#x000b1; 1.02</td><td style="text-align: center;" rowspan="1" colspan="1">0.423</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">1.30 &#x000b1; 0.61</td><td style="text-align: center;" rowspan="1" colspan="1">1.42 &#x000b1; 0.70</td><td style="text-align: center;" rowspan="1" colspan="1">0.532</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">1.07 &#x000b1; 0.27</td><td style="text-align: center;" rowspan="1" colspan="1">1.03 &#x000b1; 0.44</td><td style="text-align: center;" rowspan="1" colspan="1">0.709</td></tr><tr><td rowspan="1" colspan="1">
<bold>Discharge</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">2</td><td style="text-align: center;" rowspan="1" colspan="1">1.65 &#x000b1; 0.97</td><td style="text-align: center;" rowspan="1" colspan="1">1.50 &#x000b1; 0.98</td><td style="text-align: center;" rowspan="1" colspan="1">0.575</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">5</td><td style="text-align: center;" rowspan="1" colspan="1">1.38 &#x000b1; 0.85</td><td style="text-align: center;" rowspan="1" colspan="1">1.42 &#x000b1; 0.85</td><td style="text-align: center;" rowspan="1" colspan="1">0.872</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">7</td><td style="text-align: center;" rowspan="1" colspan="1">1.19 &#x000b1; 0.49</td><td style="text-align: center;" rowspan="1" colspan="1">1.15 &#x000b1; 0.4</td><td style="text-align: center;" rowspan="1" colspan="1">0.773</td></tr></tbody></table><table-wrap-foot><fn id="fn15383"><p><sup>a</sup> Data are presented as mean &#x000b1; SD.</p></fn><fn id="fn15384"><p><sup>b</sup> Significant at P &#x02264; 0 05.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec72045"><title>5. Discussion</title><p>The present study was the first clinical assessment of wound healing effect of AEO on post-laser resurfacing acne scar. AEO is traditionally used for wound healing (<xref rid="A16239R16" ref-type="bibr">16</xref>, <xref rid="A16239R17" ref-type="bibr">17</xref>). <italic>A. euchroma</italic> has anti-inflammatory (<xref rid="A16239R14" ref-type="bibr">14</xref>), antimicrobial (<xref rid="A16239R15" ref-type="bibr">15</xref>), and burn wound healing effects (<xref rid="A16239R18" ref-type="bibr">18</xref>). Despite the healing effects of <italic>A. euchroma</italic>, our study showed that it had no significant effect on post-laser wound in comparison with petrolatum. Some studies have evaluated the effect of <italic>A. euchroma</italic> on burn wound healing. In one experimental study, the healing effect of <italic>A. euchroma</italic> extract in second-degree burn wounds on rats was compared with and silver sulfadiazine. This study revealed that <italic>A. euchroma</italic> and silver sulfadiazine significantly improved re-epithelization, fibroblasts proliferation, and collagen bundle synthesis and had a remarkable anti-inflammatory effect. This study showed <italic>A. euchroma</italic> herbal extract was an effective treatment for second-degree burn wounds in comparison with silver sulfadiazine (<xref rid="A16239R18" ref-type="bibr">18</xref>). In another experimental study, efficacy of <italic>A. euchroma</italic> on third-degree burn-wound was assessed in 48 female Sprague-Dawley rats and showed positive effects of <italic>A. euchroma</italic> (<xref rid="A16239R20" ref-type="bibr">20</xref>). On the other hand, studies have shown that alkannin and shikonin, the main components of <italic>A. euchroma,</italic> were active against methicillin-resistant <italic>Staphylococcus aurous</italic> and vancomycin-resistant enterococci (<xref rid="A16239R21" ref-type="bibr">21</xref>). Shikonin is famous for its natural red-purple color and medicinal properties. It was used for curing burnt skin and ulcers in traditional medicine. Modern medicinal studies support its old-known uses and suggest additional applications in cancers and HIV (<xref rid="A16239R22" ref-type="bibr">22</xref>). Another in vivo study on mouse skin tissues suggested that topical treatment with shikonin could exert a potent stimulatory effect on epithelial-mesenchymal transition and suppress the expression of the associated microRNAs in skin wound healing. Altogether, these cellular and molecular data provide further evidence in support of the specific pharmacologic effects of shikonin in wound healing and immune modulation (<xref rid="A16239R23" ref-type="bibr">23</xref>). There was no clinical study on the evaluation of wound healing effects of <italic>A. euchroma</italic> in post-laser resurfacing. However, there are some studies on post-laser wound healing assessment with another burn healing drugs. For example, a research compared Aquaphor healing ointment (AHO) (AHO is a formulation of 41% petrolatum, mineral oil, ceresin, lanolin alcohol, panthenol, glycerin, and bisabolol) with Biafine topical emulsion (BTE) (BTE ingredients include purified water, liquid paraffin, ethylene glycol monostearate, stearic acid, propylene glycol, paraffin wax, squalane oil, avocado oil, trolamine/sodium alginate, triethanolamine, cetyl palmitate, methylparaben [sodium salt], sorbic acid [potassium salt], propylparaben [sodiumsalt], and fragrance) on wound healing after fractional CO2 laser resurfacing of the perioral area. Twenty patients applied AHO and BTE to opposite sides of their faces and results showed that AHO can be considered superior to BTE in accelerating healing in wound care after laser resurfacing in comparison with (<xref rid="A16239R11" ref-type="bibr">11</xref>). Another clinical study was conducted to determine the effectiveness of Cicactive (CICA) gel in wound healing after resurfacing laser in comparison with 0.1% silver sulfadiazine cream (CICA gel is a hydrocolloid gel, which is composed of sodium alginate, hydroxyprolisilane, D-panthenol, comfrey great, zinc gluconate and Uriage 30% thermal water. This agent is fragrance-free, hypoallergic, and highly tolerable, which encourages wound healing and renewal of damaged epidermis. The gel suits for treatment of skin damage caused by mechanical reasons or after medical/dermatological treatment. Studies have shown that zinc gluconate accelerates keratinization and wound healing; however, its synergistic effect with D-panthenol enhances the latter function. D-panthenol is a variant of vitamin B5, which significantly increases intracellular protein synthesis and cell renewal rate. Therefore, it decreases the duration of wound healing). CICA gel showed better results in improving wound healing than 0.1% silver sulfadiazine cream did (<xref rid="A16239R24" ref-type="bibr">24</xref>). Silver sulfadiazine is applied as standard topical therapy for patients with partial-thickness burns (<xref rid="A16239R25" ref-type="bibr">25</xref>) and BTE is used in the United States as a topical therapy for a variety of skin traumas including full-thickness wounds, pressure sores, first-degree and second-degree burns, and sunburns (<xref rid="A16239R11" ref-type="bibr">11</xref>). Despite the effect of silver sulfadiazine and BTE on burn wound healing, these studies suggested that CICA gel and AHO could be considered as better topical agents for post-laser wounds. </p><p>We compared the effects of petrolatum with AEO in post-laser resurfacing wound and despite our anticipation, petrolatum was better than AEO was in this kind of wound. As a result, the standard and usual effective burn drugs had no good effect on post-laser resurfacing wound healing. We suggested some reasons for the unsatisfactory result of AEO. The first reason might be related to wound kind that was generated in AFR. This wound is different from flames and hot water wounds (<xref rid="A16239R26" ref-type="bibr">26</xref>, <xref rid="A16239R27" ref-type="bibr">27</xref>). Another reason might be the combination of AEO and its components. Unfortunately, the compliance of AEO was not good due to its color and the creation of dryness in patients&#x02019; skin. Moreover, the sample size of our study was small. In ITM, imbalances in body temperament and humor lead to diseases and the drugs used for the treatment should possess the opposite temperament. For example a patient with hot mistemperament can be cured by a drug with cold temperament and vice versa (<xref rid="A16239R28" ref-type="bibr">28</xref>). In Canon of Avicenna, effective drugs on burn wounds have a little dryness effects (17); therefore, they are not suitable for the treatment of post-laser wounds alone because laser-induced wound has a dry temperament. Since Co<sub>2</sub> laser vaporizes intracellular and extracellular water (<xref rid="A16239R29" ref-type="bibr">29</xref>), the post-laser wound is drier than other burn wounds are. Based on the principles of ITM, drugs with moistening property must be used for laser wound treatment. Therefore, if burn drugs are combined with moistening materials, they can be ideally used for this type of wounds.</p><p>This study showed that AEO, an effective drug on burn wound healing that has been used by people for many years in many places (Iran and East of Asia), had no favorable healing effects on post-laser wounds in comparison with petrolatum. It seems that the usual burn drugs are not beneficial for the treatment of laser wounds alone, but if they are combined with moistening materials, eg, <italic>Malva sylvesteris</italic>, they might have good healing effects on post-laser wound. More studies to evaluate the combination of <italic>A. euchroma</italic> with a moistening drug for post-AFR wound healing are suggested.</p></sec></body><back><ack><p>This study was conducted as Jale Aliasl postgraduate thesis. We thank all the patients who participated in this study and the staff of the Laser Center of Shahid Beheshti University. We also thank Reyhaneh Jabarvand for her contribution to this study and valuable helps.</p></ack><fn-group><fn id="afn34070" fn-type="other"><p><bold>Authors&#x02019; Contributions:</bold>Study concept and design: Behrooz Barikbin, Mohsen Naseri, Fariba Khoshzaban, and Mohammad Kamalinejad; acquisition of data: Jale Aliasl, Fariba Khoshzaban, and Behrooz Barikbin; analysis and interpretation of data: Zahra Razzaghi and Daryush Talei; drafting the manuscript: Jale Aliasl; critical revision of the manuscript for important intellectual content: Behrooz Barikbin, Fariba Khoshzaban, Jale Aliasl, Fateme Emadi, Maryam Yousefi, Maryam Barati, Fateme Aliasl, and Parvaneh Mohseni Moghaddam; statistical analysis: Zahra Razzaghi and Daryush Talei; administrative, technical, and material support: Maryam Yousefi, Maryam Barati, Fateme Aliasl, Seyyed-Abbas Hasheminejad, Hossein and Esmailzad-Nami; study supervision: Fariba Khoshzaban and Behrooz Barikbin.</p></fn></fn-group><ref-list><title>References</title><ref id="A16239R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>CI</given-names></name><name><surname>Dover</surname><given-names>JS</given-names></name><name><surname>Kaminer</surname><given-names>MS</given-names></name></person-group><article-title>Acne scarring: a classification system and review of treatment options.</article-title><source>J Am Acad Dermatol.</source><year>2001</year><volume>45</volume><issue>1</issue><fpage>109</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1067/mjd.2001.113451</pub-id><pub-id pub-id-type="pmid">11423843</pub-id></element-citation></ref><ref id="A16239R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabbrocini</surname><given-names>G</given-names></name><name><surname>Vita</surname><given-names>VD</given-names></name><name><surname>Cozzolino</surname><given-names>A</given-names></name><name><surname>Marasca</surname><given-names>C</given-names></name><name><surname>Mazzella</surname><given-names>C</given-names></name></person-group><article-title>The Management of Atrophic Acne Scars: Overview and New Tools.</article-title><source>J Clin Exp Dermatol Res S.</source><year>2012</year><volume>5</volume><issue>2</issue><fpage>2</fpage><pub-id pub-id-type="doi">10.4172/2155-9554.S5-001</pub-id></element-citation></ref><ref id="A16239R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SS</given-names></name><name><surname>Khalid</surname><given-names>AN</given-names></name><name><surname>Graber</surname><given-names>NJ</given-names></name><name><surname>Fedok</surname><given-names>FG</given-names></name></person-group><article-title>Current trends in facial resurfacing: a survey of American Academy of Facial Plastic and Reconstructive Surgery members.</article-title><source>Arch Facial Plast Surg.</source><year>2010</year><volume>12</volume><issue>1</issue><fpage>65</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/archfacial.2009.97</pub-id><pub-id pub-id-type="pmid">20083745</pub-id></element-citation></ref><ref id="A16239R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asilian</surname><given-names>A</given-names></name><name><surname>Salimi</surname><given-names>E</given-names></name><name><surname>Faghihi</surname><given-names>G</given-names></name><name><surname>Dehghani</surname><given-names>F</given-names></name><name><surname>Tajmirriahi</surname><given-names>N</given-names></name><name><surname>Hosseini</surname><given-names>SM</given-names></name></person-group><article-title>Comparison of Q-Switched 1064-nm Nd: YAG laser and fractional CO2 laser efficacies on improvement of atrophic facial acne scar.</article-title><source>J Res Med Sci.</source><year>2011</year><volume>16</volume><issue>9</issue><fpage>1189</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">22973388</pub-id></element-citation></ref><ref id="A16239R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fife</surname><given-names>DJ</given-names></name><name><surname>Fitzpatrick</surname><given-names>RE</given-names></name><name><surname>Zachary</surname><given-names>CB</given-names></name></person-group><article-title>Complications of fractional CO2 laser resurfacing: four cases.</article-title><source>Lasers Surg Med.</source><year>2009</year><volume>41</volume><issue>3</issue><fpage>179</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1002/lsm.20753</pub-id><pub-id pub-id-type="pmid">19291745</pub-id></element-citation></ref><ref id="A16239R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tierney</surname><given-names>EP</given-names></name><name><surname>Eisen</surname><given-names>RF</given-names></name><name><surname>Hanke</surname><given-names>CW</given-names></name></person-group><article-title>Fractionated CO2 laser skin rejuvenation.</article-title><source>Dermatol Ther.</source><year>2011</year><volume>24</volume><issue>1</issue><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1111/j.1529-8019.2010.01377.x</pub-id><pub-id pub-id-type="pmid">21276157</pub-id></element-citation></ref><ref id="A16239R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saedi</surname><given-names>N</given-names></name><name><surname>Jalian</surname><given-names>HR</given-names></name><name><surname>Petelin</surname><given-names>A</given-names></name><name><surname>Zachary</surname><given-names>C</given-names></name></person-group><article-title>Fractionation: past, present, future.</article-title><source>Semin Cutan Med Surg.</source><year>2012</year><volume>31</volume><issue>2</issue><fpage>105</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.sder.2012.02.003</pub-id><pub-id pub-id-type="pmid">22640430</pub-id></element-citation></ref><ref id="A16239R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trelles</surname><given-names>MA</given-names></name><name><surname>Shohat</surname><given-names>M</given-names></name><name><surname>Urdiales</surname><given-names>F</given-names></name></person-group><article-title>Safe and effective one-session fractional skin resurfacing using a carbon dioxide laser device in super-pulse mode: a clinical and histologic study.</article-title><source>Aesthetic Plast Surg.</source><year>2011</year><volume>35</volume><issue>1</issue><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s00266-010-9553-3</pub-id><pub-id pub-id-type="pmid">20814788</pub-id></element-citation></ref><ref id="A16239R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobanko</surname><given-names>JF</given-names></name><name><surname>Alster</surname><given-names>TS</given-names></name></person-group><article-title>Laser treatment for improvement and minimization of facial scars.</article-title><source>Facial Plast Surg Clin North Am.</source><year>2011</year><volume>19</volume><issue>3</issue><fpage>527</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.fsc.2011.06.006</pub-id><pub-id pub-id-type="pmid">21856540</pub-id></element-citation></ref><ref id="A16239R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimber</surname><given-names>MP</given-names></name><name><surname>Mansbridge</surname><given-names>JN</given-names></name><name><surname>Taylor</surname><given-names>M</given-names></name><name><surname>Stockton</surname><given-names>T</given-names></name><name><surname>Hubka</surname><given-names>M</given-names></name><name><surname>Baumgartner</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Human cell-conditioned media produced under embryonic-like conditions result in improved healing time after laser resurfacing.</article-title><source>Aesthetic Plast Surg.</source><year>2012</year><volume>36</volume><issue>2</issue><fpage>431</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s00266-011-9787-8</pub-id><pub-id pub-id-type="pmid">21735336</pub-id></element-citation></ref><ref id="A16239R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarnoff</surname><given-names>DS</given-names></name></person-group><article-title>A comparison of wound healing between a skin protectant ointment and a medical device topical emulsion after laser resurfacing of the perioral area.</article-title><source>J Am Acad Dermatol.</source><year>2011</year><volume>64</volume><issue>3 Suppl</issue><fpage>S36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2010.11.014</pub-id><pub-id pub-id-type="pmid">21247664</pub-id></element-citation></ref><ref id="A16239R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annan</surname><given-names>K</given-names></name><name><surname>Houghton</surname><given-names>PJ</given-names></name></person-group><article-title>Antibacterial, antioxidant and fibroblast growth stimulation of aqueous extracts of Ficus asperifolia Miq. and Gossypium arboreum L., wound-healing plants of Ghana.</article-title><source>J Ethnopharmacol.</source><year>2008</year><volume>119</volume><issue>1</issue><fpage>141</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.06.017</pub-id><pub-id pub-id-type="pmid">18638536</pub-id></element-citation></ref><ref id="A16239R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajaei</surname><given-names>P</given-names></name><name><surname>Mohamadi</surname><given-names>N</given-names></name></person-group><article-title>Ethnobotanical study of medicinal plants of hezar mountain allocated in South East of iran.</article-title><source>Iran J Pharm Res.</source><year>2012</year><volume>11</volume><issue>4</issue><fpage>1153</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">24250549</pub-id></element-citation></ref><ref id="A16239R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaith</surname><given-names>BS</given-names></name><name><surname>Kaith</surname><given-names>NS</given-names></name><name><surname>Chauhan</surname><given-names>NS</given-names></name></person-group><article-title>Anti-inflammatory effect of Arnebia euchroma root extracts in rats.</article-title><source>J Ethnopharmacol.</source><year>1996</year><volume>55</volume><issue>1</issue><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">9121171</pub-id></element-citation></ref><ref id="A16239R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damianakos</surname><given-names>H</given-names></name><name><surname>Kretschmer</surname><given-names>N</given-names></name><name><surname>Syklowska-Baranek</surname><given-names>K</given-names></name><name><surname>Pietrosiuk</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>Chinou</surname><given-names>I</given-names></name></person-group><article-title>Antimicrobial and cytotoxic isohexenylnaphthazarins from Arnebia euchroma (Royle) Jonst. (Boraginaceae) callus and cell suspension culture.</article-title><source>Molecules.</source><year>2012</year><volume>17</volume><issue>12</issue><fpage>14310</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.3390/molecules171214310</pub-id><pub-id pub-id-type="pmid">23208466</pub-id></element-citation></ref><ref id="A16239R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghili</surname><given-names>MH</given-names></name></person-group><article-title>Gharabadin kabir.</article-title><source>Tehran Med Univ Iran.</source><year>2009</year><volume>2</volume><fpage>900</fpage></element-citation></ref><ref id="A16239R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aliasl</surname><given-names>J</given-names></name><name><surname>Khoshzaban</surname><given-names>F</given-names></name></person-group><article-title>Traditional Herbal Remedies for Burn Wound Healing in Canon of Avicenna.</article-title><source>Jundishapur J Nat Pharm Prod.</source><year>2013</year><volume>8</volume><issue>4</issue><fpage>192</fpage></element-citation></ref><ref id="A16239R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashkani-Esfahani</surname><given-names>S</given-names></name><name><surname>Imanieh</surname><given-names>MH</given-names></name><name><surname>Khoshneviszadeh</surname><given-names>M</given-names></name><name><surname>Meshksar</surname><given-names>A</given-names></name><name><surname>Noorafshan</surname><given-names>A</given-names></name><name><surname>Geramizadeh</surname><given-names>B</given-names></name><etal>et al.</etal></person-group><article-title>The healing effect of arnebia euchroma in second degree burn wounds in rat as an animal model.</article-title><source>Iran Red Crescent Med J.</source><year>2012</year><volume>14</volume><issue>2</issue><fpage>70</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">22737558</pub-id></element-citation></ref><ref id="A16239R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltanian</surname><given-names>AR</given-names></name><name><surname>Mehdibarzi</surname><given-names>D</given-names></name><name><surname>Faghihzadeh</surname><given-names>S</given-names></name><name><surname>Naseri</surname><given-names>M</given-names></name><name><surname>Gerami</surname><given-names>A</given-names></name></person-group><article-title>Mixture of Arnebia euchroma and Matricaria chamomilla (Marhame-Mafasel) for pain relief of osteoarthritis of the knee - a two-treatment, two-period crossover trial.</article-title><source>Arch Med Sci.</source><year>2010</year><volume>6</volume><issue>6</issue><fpage>950</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.5114/aoms.2010.19307</pub-id><pub-id pub-id-type="pmid">22427772</pub-id></element-citation></ref><ref id="A16239R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashkani Esfahani</surname><given-names>S</given-names></name><name><surname>Imanieh</surname><given-names>MH</given-names></name><name><surname>Meshksar</surname><given-names>A</given-names></name><name><surname>Khoshneviszadeh</surname><given-names>M</given-names></name><name><surname>Noorafshan</surname><given-names>A</given-names></name><name><surname>Geramizadeh</surname><given-names>B</given-names></name><etal>et al.</etal></person-group><article-title>Topical Arnebia euchroma gel enhanced fibroblast proliferation, vascularization and collagen synthesis in the healing process of third degree burn wounds.</article-title><source>Int Res J Pharm Pharmacol.</source><year>2012</year><volume>2</volume><issue>10</issue></element-citation></ref><ref id="A16239R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>CC</given-names></name><name><surname>Syu</surname><given-names>WJ</given-names></name><name><surname>Li</surname><given-names>SY</given-names></name><name><surname>Lin</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>GH</given-names></name><name><surname>Sun</surname><given-names>CM</given-names></name></person-group><article-title>Antimicrobial activities of naphthazarins from Arnebia euchroma.</article-title><source>J Nat Prod.</source><year>2002</year><volume>65</volume><issue>12</issue><fpage>1857</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1021/np010599w</pub-id><pub-id pub-id-type="pmid">12502328</pub-id></element-citation></ref><ref id="A16239R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghbeen</surname><given-names>K</given-names></name><name><surname>Pourmolaei</surname><given-names>S</given-names></name><name><surname>Mareftjo</surname><given-names>MJ</given-names></name><name><surname>Mousavi</surname><given-names>A</given-names></name><name><surname>Akbari Noghabi</surname><given-names>K</given-names></name><name><surname>Hosseini Shirazi</surname><given-names>F</given-names></name><etal>et al.</etal></person-group><article-title>Detailed investigations on the solid cell culture and antimicrobial activities of the Iranian Arnebia euchroma.</article-title><source>J Biomed Biotechnol.</source><year>2011</year><volume>2011</volume><fpage>165852</fpage><pub-id pub-id-type="doi">10.1155/2011/165852</pub-id><pub-id pub-id-type="pmid">21772789</pub-id></element-citation></ref><ref id="A16239R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>SY</given-names></name><name><surname>Peng</surname><given-names>AP</given-names></name><name><surname>Huang</surname><given-names>LT</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Lan</surname><given-names>CW</given-names></name><name><surname>Yang</surname><given-names>NS</given-names></name></person-group><article-title>The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing.</article-title><source>Evid Based Complement Alternat Med.</source><year>2013</year><volume>2013</volume><fpage>262796</fpage><pub-id pub-id-type="doi">10.1155/2013/262796</pub-id><pub-id pub-id-type="pmid">23861701</pub-id></element-citation></ref><ref id="A16239R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehsani</surname><given-names>A</given-names></name><name><surname>Miresmaeli</surname><given-names>M</given-names></name><name><surname>Montaser Kouhsari</surname><given-names>L</given-names></name><name><surname>Ahmadi</surname><given-names>H</given-names></name><name><surname>Hoseini</surname><given-names>M</given-names></name></person-group><article-title>Efficacy of CICACTIVE&#x000ae; versus Silversulfadiazine 0.1% cream of facial wound healing in patients treated with Erbum-YAG resurfacing laser: A single blind randomized clinical trial(letter to editor) .</article-title><source>Iran J Dermatol.</source><year>2011</year><volume>14</volume><issue>2</issue><fpage>119</fpage><lpage>20</lpage></element-citation></ref><ref id="A16239R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>AC</given-names></name><name><surname>Rashid</surname><given-names>RM</given-names></name><name><surname>Falzon</surname><given-names>L</given-names></name><name><surname>Elamin</surname><given-names>EM</given-names></name><name><surname>Zehtabchi</surname><given-names>S</given-names></name></person-group><article-title>Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers.</article-title><source>J Am Acad Dermatol.</source><year>2012</year><volume>66</volume><issue>5</issue><fpage>e159</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2010.06.014</pub-id><pub-id pub-id-type="pmid">20724028</pub-id></element-citation></ref><ref id="A16239R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hantash</surname><given-names>BM</given-names></name><name><surname>Bedi</surname><given-names>VP</given-names></name><name><surname>Kapadia</surname><given-names>B</given-names></name><name><surname>Rahman</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Tanner</surname><given-names>H</given-names></name><etal>et al.</etal></person-group><article-title>In vivo histological evaluation of a novel ablative fractional resurfacing device.</article-title><source>Lasers Surg Med.</source><year>2007</year><volume>39</volume><issue>2</issue><fpage>96</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1002/lsm.20468</pub-id><pub-id pub-id-type="pmid">17311274</pub-id></element-citation></ref><ref id="A16239R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>AR</given-names></name></person-group><article-title>Studies of Thermal Injury: III. The Pathology and Pathogenesis of Cutaneous Burns. An Experimental Study.</article-title><source>Am J Pathol.</source><year>1947</year><volume>23</volume><issue>6</issue><fpage>915</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">19970971</pub-id></element-citation></ref><ref id="A16239R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaeizadeh</surname><given-names>H</given-names></name><name><surname>Alizadeh</surname><given-names>M</given-names></name><name><surname>Naseri</surname><given-names>M</given-names></name><name><surname>Shams Ardakani</surname><given-names>MR</given-names></name></person-group><article-title>The traditional Iranian medicine point of view on health and disease.</article-title><source>Iran J Public Health.</source><year>2009</year><volume>38</volume><issue>Suppl. 1</issue><fpage>169</fpage><lpage>72</lpage></element-citation></ref><ref id="A16239R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapas</surname><given-names>AM</given-names></name><name><surname>Brightman</surname><given-names>L</given-names></name><name><surname>Sukal</surname><given-names>S</given-names></name><name><surname>Hale</surname><given-names>E</given-names></name><name><surname>Daniel</surname><given-names>D</given-names></name><name><surname>Bernstein</surname><given-names>LJ</given-names></name><etal>et al.</etal></person-group><article-title>Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing.</article-title><source>Lasers Surg Med.</source><year>2008</year><volume>40</volume><issue>6</issue><fpage>381</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1002/lsm.20659</pub-id><pub-id pub-id-type="pmid">18649382</pub-id></element-citation></ref></ref-list></back></article>